Stock News

Bio Techne (TECH) Holder Spark Investment Management Has Cut Position by $2.33 Million as Stock Price Rose; Medifast (MED) Market Valuation Rose While Hl Financial Services Upped Holding

Bio-Techne Corporation (NASDAQ:TECH) Logo

Hl Financial Services Llc increased its stake in Medifast Inc (MED) by 663.15% based on its latest 2017Q4 regulatory filing with the SEC. Hl Financial Services Llc bought 59,107 shares as the company’s stock rose 23.31% while stock markets declined. The institutional investor held 68,020 shares of the packaged foods company at the end of 2017Q4, valued at $4.75 million, up from 8,913 at the end of the previous reported quarter. Hl Financial Services Llc who had been investing in Medifast Inc for a number of months, seems to be bullish on the $1.57B market cap company. The stock increased 0.13% or $0.18 during the last trading session, reaching $130.38. About 2,934 shares traded. Medifast, Inc. (NYSE:MED) has risen 107.05% since May 17, 2017 and is uptrending. It has outperformed by 95.50% the S&P500.

Spark Investment Management Llc decreased its stake in Bio Techne Corp (TECH) by 80.09% based on its latest 2017Q4 regulatory filing with the SEC. Spark Investment Management Llc sold 18,100 shares as the company’s stock rose 14.38% while stock markets declined. The hedge fund held 4,500 shares of the biological products (no diagnostic substances) company at the end of 2017Q4, valued at $582,000, down from 22,600 at the end of the previous reported quarter. Spark Investment Management Llc who had been investing in Bio Techne Corp for a number of months, seems to be less bullish one the $5.69 billion market cap company. The stock decreased 0.23% or $0.35 during the last trading session, reaching $151.42. About 8,975 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 45.31% since May 17, 2017 and is uptrending. It has outperformed by 33.76% the S&P500.

Analysts await Bio-Techne Corporation (NASDAQ:TECH) to report earnings on August, 14. They expect $1.19 earnings per share, up 16.67% or $0.17 from last year’s $1.02 per share. TECH’s profit will be $44.71 million for 31.81 P/E if the $1.19 EPS becomes a reality. After $1.13 actual earnings per share reported by Bio-Techne Corporation for the previous quarter, Wall Street now forecasts 5.31% EPS growth.

Investors sentiment decreased to 0.98 in Q4 2017. Its down 0.23, from 1.21 in 2017Q3. It is negative, as 27 investors sold TECH shares while 88 reduced holdings. 34 funds opened positions while 79 raised stakes. 35.53 million shares or 1.06% less from 35.91 million shares in 2017Q3 were reported. Veritable Limited Partnership stated it has 0.01% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). California Pub Employees Retirement System owns 75,930 shares. Riverhead Capital Ltd Liability Corp holds 4,086 shares. Parametric Portfolio Associate Limited Liability Co holds 82,902 shares. Df Dent And reported 1.28% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Eagle Asset accumulated 0.04% or 56,837 shares. Moreover, Winfield Associates Inc has 0% invested in Bio-Techne Corporation (NASDAQ:TECH) for 5 shares. Aqr Mngmt Limited Co owns 8,836 shares or 0% of their US portfolio. Columbia Wanger Asset Llc accumulated 264,889 shares. State Street holds 1.01 million shares. Amundi Pioneer Asset Management has 0.02% invested in Bio-Techne Corporation (NASDAQ:TECH) for 75,385 shares. State Board Of Administration Of Florida Retirement System invested 0.02% in Bio-Techne Corporation (NASDAQ:TECH). Price T Rowe Associates Md holds 0% or 14,330 shares in its portfolio. Amer Mngmt has 0.09% invested in Bio-Techne Corporation (NASDAQ:TECH). The Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Bio-Techne Corporation (NASDAQ:TECH).

Among 9 analysts covering BIO-TECHNE Corp (NASDAQ:TECH), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. BIO-TECHNE Corp had 25 analyst reports since August 18, 2015 according to SRatingsIntel. The stock has “Buy” rating by Robert W. Baird on Tuesday, October 31. Leerink Swann reinitiated Bio-Techne Corporation (NASDAQ:TECH) on Thursday, November 10 with “Outperform” rating. Zacks upgraded the stock to “Hold” rating in Tuesday, September 22 report. The stock has “Buy” rating by Robert W. Baird on Tuesday, February 6. The company was initiated on Thursday, February 9 by Citigroup. The company was maintained on Thursday, May 3 by Leerink Swann. The stock has “Hold” rating by Stephens on Wednesday, February 7. The stock has “Sell” rating by Zacks on Tuesday, September 1. As per Wednesday, August 9, the company rating was maintained by Deutsche Bank. Deutsche Bank maintained the shares of TECH in report on Thursday, May 3 with “Buy” rating.

Since February 13, 2018, it had 0 buys, and 2 insider sales for $845,235 activity. 5,000 shares were sold by Dinarello Charles A, worth $680,303.

Spark Investment Management Llc, which manages about $1.26B and $1.87 billion US Long portfolio, upped its stake in Zynga Inc (NASDAQ:ZNGA) by 1.50M shares to 4.24M shares, valued at $16.97M in 2017Q4, according to the filing. It also increased its holding in Fiat Chrysler Automobiles N by 108,900 shares in the quarter, for a total of 933,400 shares, and has risen its stake in Transalta Corp (NYSE:TAC).

More important recent Bio-Techne Corporation (NASDAQ:TECH) news were published by: Investingnews.com which released: “5 Top Weekly NASDAQ Tech Stocks: Index Shifts Gear” on May 13, 2018, also Investingnews.com published article titled: “5 Top Weekly NASDAQ Tech Stocks: Index Dip Continues”, Seekingalpha.com published: “Bio-Techne (TECH) Q3 2018 Results – Earnings Call Transcript” on May 02, 2018. More interesting news about Bio-Techne Corporation (NASDAQ:TECH) was released by: Forbes.com and their article: “New High For Apple But These 5 Other Nasdaq Favorites Failed To Get There” with publication date: May 05, 2018.

Among 3 analysts covering Medifast (NYSE:MED), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Medifast had 8 analyst reports since August 10, 2015 according to SRatingsIntel. Wunderlich initiated Medifast, Inc. (NYSE:MED) on Friday, January 29 with “Hold” rating. The rating was downgraded by Sidoti on Thursday, April 19 to “Neutral”. The rating was upgraded by Sidoti on Monday, January 11 to “Buy”. The firm has “Hold” rating by Zacks given on Monday, August 10. The stock of Medifast, Inc. (NYSE:MED) earned “Neutral” rating by Sidoti on Monday, November 30. The stock of Medifast, Inc. (NYSE:MED) earned “Buy” rating by DA Davidson on Wednesday, August 16. The stock of Medifast, Inc. (NYSE:MED) has “Buy” rating given on Monday, October 5 by Sidoti. The stock has “Buy” rating by DA Davidson on Friday, September 15.

Since March 8, 2018, it had 0 insider buys, and 3 selling transactions for $4.87 million activity. CONNOLLY CHARLES P had sold 8,000 shares worth $727,600 on Friday, March 9.

Investors sentiment increased to 1.33 in 2017 Q4. Its up 0.33, from 1 in 2017Q3. It increased, as 14 investors sold MED shares while 56 reduced holdings. 36 funds opened positions while 57 raised stakes. 10.23 million shares or 0.32% more from 10.20 million shares in 2017Q3 were reported. Us Financial Bank De holds 708 shares or 0% of its portfolio. Moreover, Swiss Natl Bank has 0% invested in Medifast, Inc. (NYSE:MED). Highbridge Cap Limited Co holds 0% or 2,991 shares in its portfolio. Panagora Asset Incorporated has invested 0% in Medifast, Inc. (NYSE:MED). California Public Employees Retirement Systems holds 0.01% in Medifast, Inc. (NYSE:MED) or 67,292 shares. Td Asset Mgmt Inc has invested 0% of its portfolio in Medifast, Inc. (NYSE:MED). Convergence Inv Prns Limited Liability Company reported 7,081 shares. 11,475 are owned by Ny State Teachers Retirement. First Manhattan accumulated 700 shares. Acadian Asset Mngmt Lc stated it has 0.14% in Medifast, Inc. (NYSE:MED). Chicago Equity Partners Ltd invested in 0.03% or 12,010 shares. Los Angeles Cap And Equity invested in 27,298 shares. 6 were accumulated by Parkside Bancorporation Tru. The New Jersey-based Bessemer Grp has invested 0% in Medifast, Inc. (NYSE:MED). Meeder Asset Management reported 0.01% stake.

Medifast, Inc. (NYSE:MED) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *